A proposed protocol of derived mesenchymal stem cells for the treatment of COVID-19 patients

Recent reports have shown that mesenchymal stem cells (MSC) could be used for transplantation in various diseases. Mesenchymal stem cells exhibit remarkable plasticity and harbor potential for use in therapeutic applications while mesenchymal stem cell research could lead to many therapies becoming available to treat or repair injured or diseased tissues in a range of diseases, such as COVID-19-related pneumonia.

Please enter your email to access content Read now